Tumor‐infiltrating CD4+ or CD8+ T cells by tissue microarray‐based immunohistochemistry (IHC) were reported in association with response to neoadjuvant chemotherapy.18, 19, 20. The gene discussed is CD8A; the disease is neoplasm.